Loading company…
Synkrino Biotherapeutics, Inc. runs an AI-powered biotech platform that discovers and develops drug targets from patients' immune systems.
Founded in 2018 and based in Berkeley, California, US, Synkrino Biotherapeutics, Inc. operates an AI-powered biotech platform. The platform discovers and develops drug targets from the immune system of patients. The company is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in